Trials / Completed
CompletedNCT01803022
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 419 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study purpose is to document the prescription and the use of Low Molecular Weight Heparin in usual medical practice in patients with cancer and established Venous Thromboembolism. This study also aims at gathering epidemiological data on the Low Molecular Weight Heparin therapy of Venous Thromboembolism in patients with cancer.
Conditions
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2013-03-04
- Last updated
- 2018-02-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01803022. Inclusion in this directory is not an endorsement.